Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Budesonide for Acute Mountain Sickness
NCT02811016Phase 1Completed
- Sponsor
- Salzburger Landeskliniken
- Start
- Jun 2016
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of budesonide in acute mountain sickness (AMS) (3 arms), sponsored by Salzburger Landeskliniken. Primary endpoint: Incidence of acute mountain sickness. Started Jun 2016; status: completed.
02
Drugs
budesonide
03
Conditions
acute mountain sickness (AMS)
Beyond the preview
Go deeper on NCT02811016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02811016.